top of page

Mariana Oncology’s CEO talks about radiopharmaceuticals and last week’s $175M Series B financing

Simon Read discusses the use cases for radiopharmaceuticals, why Mariana has chosen small cell lung cancer for its first indication, and investing in CMC early.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page